Quantum Genomics
Developing BAPAIs for hypertension
- B2B
About Quantum Genomics
Quantum Genomics develops BAPAIs to treat high blood pressure and related cardiovascular risks by inhibiting brain Aminopeptidase A, aiming for partnerships with major pharmaceutical companies
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2006
- Revenue
- $2.3M – $18.5MTamtam estimate
- Website
- quantum-genomics.com
Quantum Genomics at a glance
Quantum Genomics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Paris, Île-de-France, France.
Quantum Genomics was founded in 2006.
Quantum Genomics has 1–10 employees.
Quantum Genomics's revenue is $2.3M – $18.5M (Tamtam estimate).
Selling to companies like Quantum Genomics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies